Laura Deming
7 statements across 1 episodes · 3 bullish · 1 bearish · 1 people on the record · first statement Nov 26, 2018 by Laura Deming · said 3 times in 2 episodes since 2020 · across every show →
On the record as a speaker too: Laura Deming's record, appearances and statements → this page counts the times other people say the name.
Mentions by year
brought up most by Fred Turner (2), Dylan Field (1)
tap a year for its mentions
2026 2 mentions in 1 episode
Everything said about Laura Deming, oldest first
Nov 26, 2018
Nov 26, 2018 negative
Deming: VC value creation is limited by rigid fund structure norms
“I think the diversity of fun types. I think we've been artificially constrained by a perception that it's hard to raise a new structure of fun because LPs just kind of, like, amorphously won't like it. I think that's really cut down on the value to be created …”
Nov 26, 2018 positive
Deming: Biotech value stems from founder-driven decisions, not initial thesis
“And I think, you know, maybe sometimes focusing on the thesis of an investment can blind you to the fact that most of the value in biotech comes from the eventual trajectory of the company that's unpredictable at the start. And that trajectory is absolutely di…”
Nov 26, 2018 positive
Deming: Internal biotech studio builds yield higher equity and easier LP pitches
“I mean, I think it's a great strategy. It's great for the VCs for certain parameters. I think the likelihood of success is slightly higher. The equity stakes are definitely higher, and there's a better pitch to LPs in the short term.”
Nov 26, 2018
Nov 26, 2018
Deming: Biotech VC is constrained by founder talent, not funding
“And so I think the fascinating thing is, you know, I always assumed from the outside that biotech venture capital was really limited by dollars, and I think it used to be, but I think the fascinating fact is now it's all about talent, and just, you know, we're…”
Nov 26, 2018 positive